Given that STIL is up-regulated in lung cancer and associated with worse prognosis (Fig. 1), we first examined its oncogenic properties in two NSCLC cell lines, NCI-H1299 and NCI-H2009, which expressed high levels of STIL mRNA. Here, STIL is linked to lung cancer.